Mélanome métastatique thérapies ciblées/immunothérapie
Mélanome métastatique
thérapies
ciblées/immunothérapie
Dr Jean Paul Salmon Pr Guy
Jerusalem
CHR Liège, le 09 mars 2017
Overall Survival Metastatic Melanoma<br />1-year OS Phase III Studies
Presented By Georgina Long at 2016 ASCO Annual Meeting
Overall Survival in Melanoma
Presented By Georgina Long at 2016 ASCO Annual Meeting
Two Paradigms for Advancing the Therapy of
Metastatic Melanoma
Target host
Target
tumor
Immunotherapy Targeted
Therapy
Ribas A.
Klik om het opmaakprofiel van de modelondertitel te
bewerken
Les traitements ciblés
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
1
/
36
100%
